In 2013 Mesoblast acquired Prochymal for $50m. The company hasn't really added any value to that, although it's spent a huge amount on failed trials, and is in hock for $90m with the IP pledged as security. So to me a market cap of $1B looks like a Ponzi scheme on steroids, if such a thing is possible.
ODAC August 2020 event materials, page-40
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.065(6.07%) |
Mkt cap ! $1.147B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.05 | $1.00 | $7.198M | 7.054M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 184790 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 136932 | 25 |
View Market Depth
| Last trade - 15.39pm 30/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |